Tate & Lyle PLC
Notification of a transaction by a Person Discharging Managerial Responsibilities
Tate & Lyle PLC (the 'Company') has been informed that on 7 March 2023, John Cheung, a Person Discharging Managerial Responsibilities, acquired 5,000 ordinary shares of 29 1/6 pence each in the capital of the Company at a purchase price of 791.4 pence per share.
The notification below, which has been made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.
Claire-Marie O'Grady
Company Secretary
8 March 2023
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1. |
Details of PDMR / person closely associated with them ("PCA") |
|||||
|
a) |
Name |
John Cheung |
||||
|
2. |
Reason for the notification |
|||||
|
a) |
Position / status |
Non-executive Director |
||||
|
b) |
Initial notification / amendment |
Initial notification |
||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Tate & Lyle PLC |
||||
|
b) |
LEI |
2138008K14474WPKZ244 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument Identification code |
Ordinary shares of 29 1/6 pence each in the capital of Tate & Lyle PLC
GB00BP92CJ43 |
||||
|
b) |
Nature of the transaction |
Acquisition of shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
39,750.00 |
||||
|
e) |
Date of the transaction |
2023-03-07 |
||||
|
f) |
Place of the transaction |
XLON |
||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
